Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in France
81 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleSonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Where
- Bordeaux, Caen Cedex 5, Lyon, Marseille, Rennes Cedex, Villejuif
- Age
- 18 years and over
- People
- 2,130 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07431281 · EU 2024-519787-40-00 - Phase 3Taking peopleA Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Avignon Cedex 9, Brest, Lille Cedex
- Age
- 18 years and over
- People
- 351 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT07043400 · EU 2025-522862-58-00 - Phase 2/3Taking peopleSymbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
- Where
- Marseille, Paris
- Age
- 18 years and over
- People
- 840 worldwide
- Run by
- Pfizer
See details and how to joinNCT07392892 · EU 2025-524717-86-00 - Phase 1/2Taking peopleStudy of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
- Where
- Toulouse, Villejuif
- Age
- 18 years and over
- People
- 392 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06005493 · EU 2023-504139-42-00 - Phase 2Taking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Bordeaux, Lyon, Suresnes
- Age
- 18 years to 130 years
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - Phase 1/2Taking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Angers, Bordeaux, Bron, Lille, Lyon, Montpellier, Nantes, Strasbourg
- Age
- 18 years and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - Phase 1Taking peopleEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Where
- Lyon, Paris, Saint-Herblain, Villejuif
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- SystImmune Inc.
See details and how to joinNCT05983432 - No phaseTaking peoplePOP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric
- Where
- Dijon, Grenoble, Lille, Marseille, Reims, Rouen, Saint-Cloud, Saint-Herblain, St-Malo, Tours
- Age
- 18 years and over
- People
- 72
- Run by
- GERCOR - Multidisciplinary Oncology Cooperative Group
See details and how to joinNCT06275737 - Phase 1/2Taking peopleA Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
- Where
- Clichy, Nantes, Villejuif
- Age
- 18 years and over
- People
- 630 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06427941 · EU 2025-524136-19-00 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Besançon, Levallois-Perret, Marseille, Neuilly, Paris
- Age
- 18 years and over
- People
- 2,285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - No phaseTaking peoplePAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies
- Where
- Lille
- Age
- 18 years and over
- People
- 506
- Run by
- University Hospital, Lille
See details and how to joinNCT07434739 - Phase 1Taking peopleA Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- Where
- Lyon, Marseille, Poitiers, St Herblain, Toulouse, Villejuif
- Age
- 18 years and over
- People
- 398 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT05365581 · EU 2023-504514-29-00 - No phaseTaking peopleAcupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients
- Where
- Amiens, Caen, Créteil, Grenoble, Lille, Nîmes, Paris, Saint-Cloud, Saint-Mandé, Villejuif
- Age
- 18 years and over
- People
- 182
- Run by
- GERCOR - Multidisciplinary Oncology Cooperative Group
See details and how to joinNCT05850130 - Phase 1/2Taking peopleSubstudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
- Where
- Brest, Lille, Paris
- Age
- 18 years and over
- People
- 210 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06445972 · EU 2023-509306-29-00 - Phase 3Taking peopleTrial of Trastuzumab Deruxtecan (Enhertu®) Plus Chemotherapy Plus or Minus Pembrolizumab versus Chemotherapy Plus Trastuzumab Plus or Minus Pembrolizumab in First-line Metastatic HER2-positive Gastric or GEJ Cancer
- Where
- Avignon Cedex 9, Brest, Dijon, Grenoble Cedex 9, Lille, Lyon, Montpellier Cedex 5, Nantes, Paris, Paris Cedex 12, Pessac, Poitiers, Strasbourg, Suresnes, Toulouse Cedex 9
- Age
- 18 years and over
- People
- 228 worldwide
- Run by
- Daiichi Sankyo Inc.
See details and how to join2024-513122-27-00 - Phase 2Taking peopleDEWI: Watch-and-Wait With Dostarlimab in Localized dMMR/MSI-H Gastric/GEJ Adenocarcinoma Phase II Study
- Where
- Besancon Cedex, Brest, Creteil, Lille Cedex, Lyon, Marseille, Montpellier Cedex 5, Paris, Paris Cedex 12, Pessac, Poitiers, Reims Cedex, Saint-Malo Cedex
- Age
- 18 years to 75 years
- People
- 89 worldwide
- Run by
- GERCOR - Multidisciplinary Oncology Cooperative Group
See details and how to joinNCT06059495 · EU 2023-506102-39-00 - No phaseTaking peopleR-GASTIM- Study of Gastric Cancer Operable
- Where
- Lyon
- Age
- 18 years and over
- People
- 60
- Run by
- Centre Leon Berard
See details and how to joinNCT07787052 - Phase 2Taking peopleTesting ivonescimab in combination with standard chemotherapy in advanced or metastatic gastric and gastroesophageal adenocarcinoma patients
- Where
- Bordeaux, Brest, Caen Cedex 5, Dijon, Lille, Lyon, Marseille, Paris, Poitiers, Reims, Rennes Cedex, Saint-Cloud, Saint-Herblain Cedex, Strasbourg, Toulouse, Vandouvre Les Nancy, Villejuif
- Age
- 18 years and over
- People
- 88
- Run by
- Unicancer
See details and how to joinNCT06846346 · EU 2025-520694-39-00 - Phase 1/2Taking peopleA Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Where
- Villejuif
- Age
- 18 years and over
- People
- 366 worldwide
- Run by
- Marengo Therapeutics, Inc.
See details and how to joinNCT05592626 · EU 2023-505334-10-01 - Phase 3Taking peopleStudy of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
- Where
- Avignon, Brest, Dijon, Grenoble, Lille, Lyon, Montpellier, Nantes, Paris, Pessac, Poitiers, Strasbourg, Suresnes, Toulouse
- Age
- 18 years and over
- People
- 726 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06731478 - Phase 1Taking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Bordeaux, Paris, Villejuif
- Age
- 18 years and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - Phase 1Taking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Villejuif
- Age
- 18 years and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - Phase 1Taking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Angers, Nice Cedex 2, Poitiers, Vandouvre Les Nancy, Villejuif
- Age
- 18 years and over
- People
- 1,006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - Phase 3Taking peopleCombination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas
- Where
- Brest, Clermont-Ferrand, Lyon, Marseille, Paris, Poitiers
- Age
- 18 years and over
- People
- 132
- Run by
- Centre Leon Berard
See details and how to joinNCT06346197 - No phaseTaking peopleEvaluation of Skin Tests in Biotherapy Allergies
- Where
- Angers
- Age
- 18 years and over
- People
- 70
- Run by
- University Hospital, Angers
See details and how to joinNCT06971848